Travelers With Sickle Cell Disease

被引:14
|
作者
Willen, Shaina M. [1 ]
Thornburg, Courtney D. [2 ]
Lantos, Paul M. [3 ]
机构
[1] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[2] Univ San Diego, Med Ctr, Div Pediat Hematol & Oncol, San Diego, CA 92110 USA
[3] Duke Univ, Med Ctr, Div Gen Internal Med, Durham, NC USA
基金
美国国家卫生研究院;
关键词
VENOUS THROMBOEMBOLISM; PNEUMOCOCCAL DISEASE; RISK-FACTORS; CHILDREN; ANEMIA; PROPHYLAXIS; HYDROXYUREA; PENICILLIN; MALARIA; AFRICA;
D O I
10.1111/jtm.12142
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Sickle cell disease (SCD) is the most common genetic disease among persons with African ancestry. This article provides a background to SCD and reviews many important aspects of travel preparation in this population. Methods. The medical literature was searched for studies on travel-associated preparedness and complications in individuals with SCD. Topics researched included malaria, bacterial infections, vaccinations, dehydration, altitude, air travel, and travel preparedness. Results. There is very little published literature that specifically addresses the risks faced by travelers with SCD. Rates of medical complications during travel appear to be high. There is a body of literature that describes complications of SCD in indigenous populations, particularly within Africa. The generalizability of these data to a traveler is uncertain. Combining these sources of data and the broader medical literature, we address major travel-related questions that may face a provider preparing an individual with SCD for safe travel. Conclusions. Travelers with SCD face considerable medical risks when traveling to developing tropical countries, including malaria, bacterial infections, hypovolemia, and sickle cell-associated vaso-occlusive crises. For individuals with SCD, frank counseling about the risks, vigilant preventative measures, and contingency planning for illness while abroad are necessary aspects of the pre-travel visit.
引用
收藏
页码:332 / 339
页数:8
相关论文
共 50 条
  • [21] Pulmonary hypertension and nitric oxide depletion in sickle cell disease
    Bunn, H. Franklin
    Nathan, David G.
    Dover, George J.
    Hebbel, Robert P.
    Platt, Orah S.
    Rosse, Wendell F.
    Ware, Russell E.
    BLOOD, 2010, 116 (05) : 687 - 692
  • [22] A Novel Newborn Screening Program for Sickle Cell Disease in Nigeria
    Galadanci, Aisha A.
    Ibrahim, Umma A.
    Carroll, Yvonne
    Jobbi, Yusuf D.
    Farouk, Zubaida L.
    Mukaddas, Aisha
    Hussaini, Nafiu
    Sani Musa, Bilya
    Klein, Lauren J.
    Debaun, Michael R.
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2024, 10 (04)
  • [23] Setting the Agenda for Quality Improvement in Pediatric Sickle Cell Disease
    Kenyon, Chen C.
    Kavanagh, Patricia L.
    Fiechtner, Lauren G.
    Textor, Theodora E.
    Wang, C. Jason
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2012, 104 (7-8) : 337 - 341
  • [24] An observational study of children with sickle cell disease in Kilifi, Kenya
    Sadarangani, Manish
    Makani, Julie
    Komba, Albert N.
    Ajala-Agbo, Tolu
    Newton, Charles R.
    Marsh, Kevin
    Williams, Thomas N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (06) : 675 - 682
  • [25] Sickle Cell Disease and Elective Cholecystectomy
    Leake, P. A.
    Toppin, Jp
    King, L.
    Reid, M.
    Scotto, P.
    Duncan, N. D.
    McFarlane, M. E. C.
    WEST INDIAN MEDICAL JOURNAL, 2019, 68 : 3 - 9
  • [26] Intracranial Aneurysms in Sickle Cell Disease
    Jabbarli, Ramazan
    Dinger, Thiemo F.
    Pierscianek, Daniela
    Oppong, Marvin D.
    Chen, Bixia
    Dammann, Philipp
    Wrede, Karsten H.
    Kaier, Klaus
    Koehrmann, Martin
    Forsting, Michael
    Kleinschnitz, Christoph
    Sure, Ulrich
    CURRENT NEUROVASCULAR RESEARCH, 2019, 16 (01) : 63 - 76
  • [27] Reproductive issues in sickle cell disease
    Smith-Whitley, Kim
    BLOOD, 2014, 124 (24) : 3538 - 3543
  • [28] Sickle cell retinopathy and systemic disease
    Anibire, Oladipupo O.
    Brill, Daniel A.
    Williams Jr, Basil K.
    ANNALS OF EYE SCIENCE, 2024, 9
  • [29] Kidney abnormalities in sickle cell disease
    Lopez Revuelta, K.
    Ricard Andres, M. P.
    NEFROLOGIA, 2011, 31 (05): : 591 - 601
  • [30] Clinical biomarkers in sickle cell disease
    Damanhouri, Ghazi A.
    Jarullah, Jummanah
    Marouf, Samy
    Hindawi, S. I.
    Mushtaq, Gohar
    Kamal, Mohammad A.
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2015, 22 (01) : 24 - 31